The store will not work correctly when cookies are disabled.
4-Methyl-7-phenoxy-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxide
ID: ALA4092527
PubChem CID: 69508277
Max Phase: Preclinical
Molecular Formula: C14H14N2O3S
Molecular Weight: 290.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CNS(=O)(=O)c2cc(Oc3ccccc3)ccc21
Standard InChI: InChI=1S/C14H14N2O3S/c1-16-10-15-20(17,18)14-9-12(7-8-13(14)16)19-11-5-3-2-4-6-11/h2-9,15H,10H2,1H3
Standard InChI Key: ZFVITKPIGVTYEY-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
15.6370 -11.3996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2286 -10.6871 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.8158 -11.3970 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0815 -9.4496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0803 -10.2770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7951 -10.6898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7933 -9.0369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5086 -9.4460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5121 -10.2790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9515 -10.2732 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9482 -9.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2244 -9.0242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3655 -10.6889 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6514 -10.2758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6566 -9.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9434 -9.0380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2276 -9.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2296 -10.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9435 -10.6885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2198 -8.1992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 12 1 0
9 2 1 0
2 10 1 0
10 11 1 0
11 12 1 0
5 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 290.34 | Molecular Weight (Monoisotopic): 290.0725 | AlogP: 2.16 | #Rotatable Bonds: 2 |
Polar Surface Area: 58.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.09 | CX Basic pKa: ┄ | CX LogP: 2.35 | CX LogD: 2.35 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.92 | Np Likeness Score: -0.62 |
References
1. Goffin E, Drapier T, Larsen AP, Geubelle P, Ptak CP, Laulumaa S, Rovinskaja K, Gilissen J, Tullio P, Olsen L, Frydenvang K, Pirotte B, Hanson J, Oswald RE, Kastrup JS, Francotte P.. (2018) 7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency., 61 (1): [PMID:29256599] [10.1021/acs.jmedchem.7b01323] |